Results 111 to 120 of about 60,520 (273)

Olanzapine for chemotherapy-induced nausea and vomiting: systematic review and meta-analysis

open access: yesPharmacy in practice, 2017
Background: Chemotherapy induced nausea and vomiting (CINV) remains the most distressing event in patients receiving highly emetogenic chemotherapy (HEC) or moderately emetogenic chemotherapy (MEC).
Legese Chelkeba   +5 more
semanticscholar   +1 more source

Psychotic depression associated with Graves' disease: A case report on treatment prioritization

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 4, December 2026.
Abstract Background Graves' disease can be accompanied by psychiatric symptoms, including affective and psychotic manifestations. When a well‐defined psychiatric syndrome occurs concurrently with a medical illness, determining whether it is directly attributable to the medical condition or represents an independent psychiatric disorder precipitated by ...
Ayumu Kocha   +7 more
wiley   +1 more source

Olanzapine: The game-changer “antiemetic”

open access: yesIndian Journal of Medical and Paediatric Oncology, 2019
Chemotherapy-induced nausea and vomiting (CINV) is significantly debilitating and worsens the quality of life. Olanzapine, an atypical antipsychotic drug, also has an antiemetic potential.
Manikandan Dhanushkodi
doaj   +1 more source

A case of acute lithium encephalopathy associated with elevated myelin basic protein levels in cerebrospinal fluid

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 4, December 2026.
Abstract Background Acute lithium intoxication can cause severe central nervous system (CNS) manifestations, sometimes leading to long‐term sequelae known as the syndrome of irreversible lithium‐effectuated neurotoxicity (SILENT). However, its underlying pathophysiology remains unclear.
Teruo Yokoyama   +3 more
wiley   +1 more source

Resumption of Menses and Normalisation of Body Weight in Adolescents Undergoing Specialised Treatment for Anorexia Nervosa Inpatient or Outpatient Treatment

open access: yesEuropean Eating Disorders Review, Volume 34, Issue 6, Page 1515-1527, November 2026.
ABSTRACT Objective To predict resumption of menses (ROM) in patients with anorexia nervosa (AN). Method Females aged 9–17 years with AN, receiving inpatient multimodal treatment (IMT) or family‐based treatment (FBT) underwent assessments at baseline, 6‐month and 12‐month follow‐up (12FU).
Annika Woltmann   +6 more
wiley   +1 more source

Olanzapine induced tardive dystonia in case of adolescent bipolar disorder

open access: yesJournal of Pediatric Neurosciences, 2009
Atypical antipsychotics are increasingly being associated with neurological side effects. Risperidone, quetiapine, and aripiprazole have been associated with tardive dystonia among other side effects.
Yatan Pal Singh Balhara   +2 more
doaj   +1 more source

Olanzapine Prevents the PCP-induced Reduction in the Neurite Outgrowth of Prefrontal Cortical Neurons via NRG1

open access: yesScientific Reports, 2016
Accumulating evidence suggests that reducing neurite outgrowth and synaptic plasticity plays a critical role in the pathology of cognitive deficits in schizophrenia.
Qing-Sheng Zhang   +2 more
semanticscholar   +1 more source

Psychopharmacological Prescribing Patterns Among Italian Adolescents With Anorexia Nervosa: Exploring Real‐World Treatment Practices

open access: yesEuropean Eating Disorders Review, Volume 34, Issue 6, Page 1626-1636, November 2026.
ABSTRACT Objective To investigate real‐world psychopharmacological prescribing patterns among Italian adolescents with anorexia nervosa (AN) compared with psychiatric controls without eating disorders, and to examine whether AN diagnosis independently predicts medication use after accounting for psychiatric comorbidities.
Marika Orlandi   +5 more
wiley   +1 more source

A comparative study of olanzapine versus asenapine in acute treatment of manic episode: A 3-week prospective study

open access: yesJournal of Mental Health and Human Behaviour, 2014
Introduction: Treatment of bipolar disorders has evolved over the years from conventional mood stabilizers to second-generation antipsychotics. Among the atypical antipsychotics, few have been approved by Food and Drug Administration as treatment of ...
Ajeet Sidana, Prannay Gulati, B S Chavan
doaj   +1 more source

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia

open access: yes, 2018
Hideaki Katagiri,1 Masanori Taketsuna,2 Shinpei Kondo,3 Kenta Kajimoto,4 Etsuko Aoi,5 Yuka Tanji1 1Bio-Medicines, Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan; 2Statistical Sciences, Medicines Development Unit Japan, Eli Lilly ...
Kondo S   +5 more
core  

Home - About - Disclaimer - Privacy